Listed

Nephros Inc: Form 10-Q for the period ended Jun 30, 2014

Filed with the SEC on Aug 14, 2014 and accepted by EDGAR at Aug 14, 2014, 17:25 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-04-01 to 2014-06-30$441.0kus-gaap:SalesRevenueNet
Revenue6 months2014-01-01 to 2014-06-30$915.0kus-gaap:SalesRevenueNet
Cost of revenue3 months2014-04-01 to 2014-06-30$142.0kus-gaap:CostOfGoodsSold
Cost of revenue6 months2014-01-01 to 2014-06-30$248.0kus-gaap:CostOfGoodsSold
Gross profit3 months2014-04-01 to 2014-06-30$299.0kus-gaap:GrossProfit
Gross profit6 months2014-01-01 to 2014-06-30$667.0kus-gaap:GrossProfit
Selling, general and administrative3 months2014-04-01 to 2014-06-30$700.0kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2014-01-01 to 2014-06-30$1.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-04-01 to 2014-06-30−$636.0kus-gaap:OperatingIncomeLoss
Operating income6 months2014-01-01 to 2014-06-30−$1.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2014-04-01 to 2014-06-30$17.0kus-gaap:InterestExpense
Interest expense6 months2014-01-01 to 2014-06-30$70.0kus-gaap:InterestExpense
Net income3 months2014-04-01 to 2014-06-30−$654.0kus-gaap:NetIncomeLoss
Net income6 months2014-01-01 to 2014-06-30−$1.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-04-01 to 2014-06-30−$0.03us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2014-01-01 to 2014-06-30−$0.06us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2014-01-01 to 2014-06-30−$867.0kus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2014-06-30$225.0kus-gaap:Cash
Current assetsAt period end2014-06-30$560.0kus-gaap:AssetsCurrent
Total assetsAt period end2014-06-30$2.4mus-gaap:Assets
Current liabilitiesAt period end2014-06-30$1.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-06-30$2.1mus-gaap:Liabilities
Shareholders' equityAt period end2014-06-30$216.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-14-050399. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.